Fondsen
Human Plus C.V.

Human Plus C.V.

Venture Capital
Biomedical research with potential benefit to patients often doesn’t reach the market because of lacking product development expertise combined with inadequate funding
Claim profiel
Let op

Informatie over dit fonds is gebaseerd op openbare bronnen en/of door het fonds zelf aangeleverde gegevens; FundReport is niet verantwoordelijk voor de juistheid ervan en aanvaardt geen aansprakelijkheid voor gebruik van deze informatie.

Biomedical research with potential benefit to patients often doesn’t reach the market because of lacking product development expertise combined with inadequate funding. In particular, the translational phase from basic scientific research towards product development may be inadequately funded by public funds, and is too early for private, commercial investors to step in.